Verastem, Inc. (VSTM) is a publicly traded Healthcare sector company. As of September 8, 2026, VSTM trades at $7.92 with a market cap of $742.62M and a P/E ratio of -3.48. VSTM moved +0.00% today. Year to date, VSTM is +6.22%; over the trailing twelve months it is -23.86%. Its 52-week range spans $3.43 to $11.25. Analyst consensus is strong buy with an average price target of $14.43. Rallies surfaces VSTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for VSTM shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $7.92 |
| Market Cap | $742.62M |
| P/E Ratio | -3.48 |
| EPS | $-2.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.25 |
| 52-Week Low | $3.43 |
| Volume | 137.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $87.53M |
| Net Income | $-202.70M |
| Gross Margin | 0.00% |
7 analysts cover VSTM: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.43.